{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:04:58Z","timestamp":1648638298418},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Intensiva"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.medin.2012.05.013","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T03:02:36Z","timestamp":1348542156000},"page":"124-125","source":"Crossref","is-referenced-by-count":1,"title":["L-Carnitina en la hiperamoniemia inducida por \u00e1cido valproico"],"prefix":"10.1016","volume":"38","author":[{"given":"J.P.","family":"Mart\u00edn-del Rinc\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Llompart-Pou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ferreruela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medin.2012.05.013_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","article-title":"Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy","volume":"69","author":"Mock","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.medin.2012.05.013_bib0010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2011.02550.x","article-title":"Noncirrhotic hiperammonaemic encephalopathy","volume":"31","author":"Laish","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.medin.2012.05.013_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.medin.2012.05.013_bib0020","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of L-carnitine treatment for valproate induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.medin.2012.05.013_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.genhosppsych.2011.12.009","article-title":"Valproate induced hyperammonemic encephalophaty: an update on risk factors, clinical correlates and management","volume":"34","author":"Chopra","year":"2012","journal-title":"Gen Hosp Psychiatry"}],"container-title":["Medicina Intensiva"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569112002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569112002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T15:20:13Z","timestamp":1542727213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210569112002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0210569112002045"],"URL":"https:\/\/doi.org\/10.1016\/j.medin.2012.05.013","relation":{},"ISSN":["0210-5691"],"issn-type":[{"value":"0210-5691","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}